Cornell Chang

Cornell Chang has a diverse work experience in the pharmaceutical and biotech industry. Cornell is currently working as the Director of Clinical Operations at Nkarta, Inc. since 2023. Prior to this, they served as the Associate Director of Clinical Operations at Nkarta, Inc. from 2020 to 2023. Cornell also worked as a Senior Clinical Trial Manager at Nektar Therapeutics from 2017 to 2020 and at ARMO Biosciences from 2016 to 2017. Cornell's experience includes working as a Senior Manager of Clinical Operations at Samsung Bioepis in 2015 and as a Clinical Trial Manager at Gilead Sciences in 2013-2014. Cornell has also held roles such as a Senior Clinical Operations Specialist at Actelion in 2013 and a Senior Country Study Manager at Genentech in 2012-2013. Additionally, they have experience as a Clinical Trial Manager at Exelixis, Inc. from 2008 to 2011 and as an Associate Research Scientist from 2000 to 2008. Cornell began their career as a Research Assistant at the UCSF Cancer Center from 1997 to 2000.

Cornell Chang's education history includes a Bachelor of Arts degree in Integrative Biology from the University of California, Berkeley. The specific start and end years for this degree are not provided. Additionally, Cornell Chang pursued studies in Clinical Trials Design & Management at San Francisco State University, although the details regarding the degree name and the duration of the program are not provided.